Wan‐Ting Hsu

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Role of the oral microbiota in cancer evolution and progression

Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov

Oxidative stress, aging, and diseases

Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities

The JAK/STAT signaling pathway: from bench to clinic

Statin Use Is Associated With a Lower Risk of TB

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Host-directed therapies for bacterial and viral infections

An RNA-centric dissection of host complexes controlling flavivirus infection

Fusobacterium nucleatum — symbiont, opportunist and oncobacterium

Novel biomarkers for cardiovascular risk prediction.

Targeting the JAK/STAT pathway in solid tumors

<p>Taiwan’s National Health Insurance Research Database: past and future</p>

Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan

Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort

Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19

Using The Galectin-3 Test to Predict Mortality in Heart Failure Patients: a Systematic Review and Meta-Analysis

Administration of Hypertonic Solutions for Hemorrhagic Shock: A Systematic Review and Meta-analysis of Clinical Trials

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer